GLP-1 Analogue Improves Renal Outcomes in Type 2 Diabetes GLP-1 Analogue Improves Renal Outcomes in Type 2 Diabetes

A glucagonlike peptide analogue is now shown to reduce risk of adverse renal outcomes in type 2 diabetes patients receiving usual care.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news